{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:28:14Z","timestamp":1789972094342,"version":"4.0.1"},"reference-count":90,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2,1]]},"DOI":"10.1210\/jc.2008-1531","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T04:09:14Z","timestamp":1227672554000},"page":"400-409","source":"Crossref","is-referenced-by-count":182,"title":["Clinical Review: Bisphosphonate Use in Childhood Osteoporosis"],"prefix":"10.1210","volume":"94","author":[{"given":"Laura K.","family":"Bachrach","sequence":"first","affiliation":[{"name":"Stanford University School of Medicine (L.K.B.), Stanford, California 94305"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne M.","family":"Ward","sequence":"additional","affiliation":[{"name":"Pediatric Bone Health Clinical and Research Programs (L.M.W.), Children\u2019s Hospital of Eastern Ontario, University of Ottawa, Ottawa, Canada K1H 8L1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114145940800_R1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4158\/EP.13.5.513","article-title":"Consensus and controversy regarding osteoporosis in the pediatric population.","volume":"13","author":"Bachrach","year":"2007","journal-title":"Endocr Pract"},{"key":"key\n\t\t\t\t2019041114145940800_R2","first-page":"1095","article-title":"Osteoporosis in childhood and adolescence","author":"Ward","year":"2008","journal-title":"In: Marcus R, Feldman D, Nelson DA, Rosen CJ, eds. Osteoporosis. 3rd ed. Boston: Elsevier;"},{"key":"key\n\t\t\t\t2019041114145940800_R3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bone.2007.07.008","article-title":"Osteoporosis in children and adolescents.","volume":"41","author":"Bianchi","year":"2007","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041114145940800_R4","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1359\/JBMR.050820","article-title":"Bone and body composition of children and adolescent with repeated forearm fractures.","volume":"20","author":"Goulding","year":"2005","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R5","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jpeds.2004.09.029","article-title":"First fracture is associated with increased risk of new fractures during growth.","volume":"146","author":"Goulding","year":"2005","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t2019041114145940800_R6","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1542\/peds.2005-1404","article-title":"Association between bone density and fractures in children: a systematic review and meta-analysis","volume":"117","author":"Clark","year":"2006","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t2019041114145940800_R7","first-page":"1725","article-title":"Bisphosphonates: pharmacology and use in the treatment of osteoporosis","author":"Miller","year":"2008","journal-title":"In: Marcus R, Feldman D, Nelson DA, Rosen CJ, eds. Osteoporosis. 3rd ed. Boston: Elsevier;"},{"key":"key\n\t\t\t\t2019041114145940800_R8","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00198-008-0712-1","article-title":"Case finding for the management of osteoporosis with FRAX\u00ae: assessment and intervention thresholds for the UK.","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041114145940800_R9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1138\/20080309","article-title":"The U.S. National Osteoporosis Foundation (NOF) guideline: recommendations for pharmacologic treatment.","volume":"5","author":"Cummings","year":"2008","journal-title":"IBMS Bone KEy"},{"key":"key\n\t\t\t\t2019041114145940800_R10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1440-1754.2003.00083.x","article-title":"Use of bisphosphonate therapy for osteoporosis in childhood and adolescence.","volume":"39","author":"Batch","year":"2003","journal-title":"J Paediatr Child Health"},{"key":"key\n\t\t\t\t2019041114145940800_R11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/07853890510007386","article-title":"Bisphosphonate treatment in osteogenesis imperfecta: which drug, for whom, for how long?","volume":"37","author":"Rauch","year":"2005","journal-title":"Ann Med"},{"key":"key\n\t\t\t\t2019041114145940800_R12","first-page":"CD005324","article-title":"Bisphosphonate therapy for children and adolescents with secondary osteoporosis","volume":"2007","author":"Ward","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2019041114145940800_R13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jocd.2007.12.002","article-title":"Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2007 ISCD Pediatric Position Development Conference.","volume":"11","author":"Bain","year":"2008","journal-title":"J Clin Densitom"},{"key":"key\n\t\t\t\t2019041114145940800_R14","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/cncr.22796","article-title":"Bone health in children and adolescents after allogeneic stem cell transplantation: high prevalence of vertebral compression fractures.","volume":"110","author":"Taskinen","year":"2007","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2019041114145940800_R15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/BPO.0b13e31815ff350","article-title":"Musculoskeletal manifestations in pediatric acute leukemia.","volume":"28","author":"Sinigaglia","year":"2008","journal-title":"J Pediatr Orthop"},{"key":"key\n\t\t\t\t2019041114145940800_R16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpeds.2003.08.054","article-title":"Overdiagnosis of osteoporosis in children due to misinterpretation of dual energy x-ray absorptiometry (DEXA).","volume":"144","author":"Gafni","year":"2004","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t2019041114145940800_R17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jocd.2006.02.004","article-title":"Bone density interpretation and relevance in Caucasian children aged 9\u201317 years of age: insights from a population-based fracture study.","volume":"9","author":"Jones","year":"2006","journal-title":"J Clin Densitometry"},{"key":"key\n\t\t\t\t2019041114145940800_R18","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1359\/jbmr.060601","article-title":"Association between bone mass and fractures in children: a prospective cohort study.","volume":"21","author":"Clark","year":"2006","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R19","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1359\/jbmr.070509","article-title":"Can BMD assessed by DXA at age 8 predict fracture risk in boys and girls during puberty? An eight-year prospective study.","volume":"22","author":"Flynn","year":"2007","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R20","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","article-title":"Osteogenesis imperfecta.","volume":"363","author":"Rauch","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041114145940800_R21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1359\/jbmr.1997.12.4.509","article-title":"From density to structure: growing up and growing old on the surfaces of bone.","volume":"12","author":"Seeman","year":"1997","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R22","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1359\/jbmr.040902","article-title":"Epidemiology of childhood fractures in Britain: a study using the General Practice Research Database.","volume":"19","author":"Cooper","year":"2004","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R23","first-page":"1226","article-title":"Epidemiology of fractures of the distal end of the radius in children as associated with growth","volume":"8","author":"Bailey","year":"1988","journal-title":"J Bone Joint Surg"},{"key":"key\n\t\t\t\t2019041114145940800_R24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1359\/jbmr.051215","article-title":"Childhood fractures are associated with decreased bone mass gain during puberty: an early marker of persistent bone fragility?","volume":"21","author":"Ferrari","year":"2006","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R25","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1359\/JBMR.050101","article-title":"Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children.","volume":"20","author":"Hartikka","year":"2005","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R26","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy.","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041114145940800_R27","first-page":"209","article-title":"Osteoporosis due to glucocorticoid use in children with chronic illness.","volume":"64","author":"Ward","year":"2005","journal-title":"Horm Res"},{"key":"key\n\t\t\t\t2019041114145940800_R28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1359\/jbmr.2003.18.5.913","article-title":"Children and the risk of fractures caused by oral corticosteroids.","volume":"18","author":"Van Staa","year":"2003","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R29","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1001\/jama.1994.03520240070044","article-title":"NIH consensus developmental panel on optimal calcium intake.","volume":"272","year":"1994","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041114145940800_R30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1542\/peds.2007-1894","article-title":"Vitamin D deficiency in children and its management: review of current knowledge and recommendations.","volume":"122","author":"Misra","year":"2008","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t2019041114145940800_R31","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrg1122","article-title":"Genetic regulation of osteoclast development and function.","volume":"4","author":"Teitelbaum","year":"2003","journal-title":"Nat Rev Genet"},{"key":"key\n\t\t\t\t2019041114145940800_R32","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1210\/jc.2005-2818","article-title":"Determinants of skeletal loss and recovery in anorexia nervosa.","volume":"91","author":"Miller","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114145940800_R33","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1210\/jc.2007-1434","article-title":"Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa.","volume":"93","author":"Misra","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114145940800_R34","first-page":"898","article-title":"The effect of estrogen administration on trabecular bone loss in young women with anorexia nervosa.","volume":"80","author":"Klibanski","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114145940800_R35","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1210\/jcem.87.6.8574","article-title":"Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa.","volume":"87","author":"Grinspoon","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114145940800_R36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0022-3476(99)70340-9","article-title":"The effect of a weight-bearing physical activity program on bone mineral content and estimated volumetric density in children with spastic cerebral palsy.","volume":"135","author":"Chad","year":"1999","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t2019041114145940800_R37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1359\/JBMR.040129","article-title":"Low magnitude mechanical loading is osteogenic in children with disabling conditions.","volume":"19","author":"Ward","year":"2004","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R38","first-page":"821","article-title":"Variable deficits of bone mineral despite chronic glucocorticoid therapy in pediatric patients with inflammatory diseases: a Glaser Pediatric Research Network study.","volume":"19","author":"Scheven","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114145940800_R39","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1359\/JBMR.051023","article-title":"Teriparatide [Human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis.","volume":"21","author":"Tashjian","year":"2006","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R40","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.","volume":"339","author":"Glorieux","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114145940800_R41","first-page":"1846","article-title":"Pamidronate treatment in children under 3 years of age.","volume":"85","author":"Plotkin","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114145940800_R42","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(04)16101-1","article-title":"Skeletal effects and functional outcome with olpandronate in children with osteogenesis imperfecta: a 2-year randomized placebo-controlled study.","volume":"363","author":"Sakkers","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041114145940800_R43","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1359\/JBMR.041232","article-title":"Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled trial.","volume":"20","author":"Gatti","year":"2005","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R44","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1359\/JBMR.050109","article-title":"Controlled trial of pamidronate in children with types II and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement.","volume":"20","author":"Letocha","year":"2005","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R45","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1359\/JBMR.051006","article-title":"Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta.","volume":"21","author":"DiMeglio","year":"2006","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R46","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00431-006-0399-2","article-title":"Quality of life in children with osteogenesis imperfecta treated with oral bisphosphonates (Olpadronate): a 2-year randomized placebo-controlled trial.","volume":"166","author":"Kok","year":"2007","journal-title":"Eur J Pediatr"},{"key":"key\n\t\t\t\t2019041114145940800_R47","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpeds.2006.03.013","article-title":"Early bisphosphonate treatment in infants with severe osteogenesis imperfecta.","volume":"149","author":"Antoniazzi","year":"2006","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t2019041114145940800_R48","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1067\/mpd.2002.128207","article-title":"Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled trial.","volume":"141","author":"Henderson","year":"2002","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t2019041114145940800_R49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1399-3046.2004.00191.x","article-title":"Treatment of osteopenia and osteoporosis in renal transplant children and adolescents.","volume":"8","author":"El Husseini","year":"2004","journal-title":"Pediatr Transplant"},{"key":"key\n\t\t\t\t2019041114145940800_R50","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/jc.2004-1659","article-title":"Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial.","volume":"90","author":"Golden","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114145940800_R51","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00198-004-1731-1","article-title":"The efficacy of acute administration of pamidronate on the conservation of bone mass following severe burn injury in children: a double-blind, randomized, controlled study.","volume":"16","author":"Klein","year":"2005","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041114145940800_R52","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/rheumatology\/keh538","article-title":"Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment.","volume":"44","author":"Rudge","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t2019041114145940800_R53","doi-asserted-by":"crossref","first-page":"c81","DOI":"10.1159\/000089664","article-title":"Pamidronate therapy for preventing steroid-induced osteoporosis in children with nephropathy","volume":"102","author":"Kim","year":"2006","journal-title":"Nephron Clin Pract"},{"issue":"Suppl 6","key":"key\n\t\t\t\t2019041114145940800_R54","first-page":"33","article-title":"Treatment and prevention of osteoporosis in juvenile chronic arthritis with disodium clodronate","volume":"9","author":"Lepore","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"key\n\t\t\t\t2019041114145940800_R55","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00467-004-1790-8","article-title":"Pamidronate treatment of pediatric fracture patients on chronic steroid therapy.","volume":"20","author":"Acott","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t2019041114145940800_R56","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/1529-0131(200009)43:9<1960::AID-ANR6>3.0.CO;2-J","article-title":"Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study.","volume":"43","author":"Bianchi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2019041114145940800_R57","first-page":"L18","article-title":"Pediatric randomized placebo-controlled trial of alendronate for glucocorticoid-associated osteoporosis","volume":"56","author":"Von Scheven","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2019041114145940800_R58","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bbmt.2007.02.001","article-title":"Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease.","volume":"13","author":"Carpenter","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"key\n\t\t\t\t2019041114145940800_R59","first-page":"S12","article-title":"Alendronate in the treatment of pediatric osteogenesis imperfecta","volume":"19","author":"Glorieux","year":"2004","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R60","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1515\/JPEM.2003.16.6.887","article-title":"Low-dose intravenous pamidronate reduces fractures in childhood osteoporosis.","volume":"16","author":"Gandrud","year":"2003","journal-title":"J Pediatr Endocrinol"},{"key":"key\n\t\t\t\t2019041114145940800_R61","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1067\/mpd.2003.137","article-title":"Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions.","volume":"142","author":"Steelman","year":"2003","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t2019041114145940800_R62","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1017\/S0012162206001526","article-title":"Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study.","volume":"48","author":"Plotkin","year":"2006","journal-title":"Dev Med Child Neurol"},{"key":"key\n\t\t\t\t2019041114145940800_R63","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jpeds.2004.06.066","article-title":"Short-term safety assessment in the use of intravenous zoledronic acid in children.","volume":"145","author":"Hogler","year":"2004","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t2019041114145940800_R64","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women.","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114145940800_R65","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jc.2005-0057","article-title":"Long-term safety of bisphosphonates.","volume":"90","author":"Ott","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114145940800_R66","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1359\/jbmr.2003.18.4.610","article-title":"Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy.","volume":"18","author":"Rauch","year":"2003","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R67","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1359\/JBMR.051207","article-title":"Cyclical intravenous pamidronate treatment affects metaphyseal modeling in growing patients with osteogenesis imperfecta.","volume":"21","author":"Land","year":"2006","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R68","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1210\/jc.2005-2036","article-title":"Pamidronate in children with osteogenesis imperfecta: histomorphic effects of long-term therapy.","volume":"91","author":"Rauch","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114145940800_R69","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bone.2007.04.195","article-title":"Pamidronate preserves bone mass for at least 2 years following acute administration for pediatric burn injury.","volume":"41","author":"Przkora","year":"2007","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041114145940800_R70","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bone.2006.11.020","article-title":"Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta.","volume":"40","author":"Rauch","year":"2007","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041114145940800_R71","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1210\/jc.2005-2413","article-title":"Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation.","volume":"91","author":"Rauch","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114145940800_R72","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00198-007-0330-3","article-title":"Can bisphosphonate treatment be stopped in a growing child with skeletal fragility?","volume":"18","author":"Ward","year":"2007","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041114145940800_R73","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bone.2007.05.002","article-title":"Acute phase response and mineral status following low dose intravenous zoledronic acid in children.","volume":"41","author":"Munns","year":"2007","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041114145940800_R74","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bone.2008.01.003","article-title":"Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.","volume":"42","author":"Rizzoli","year":"2008","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041114145940800_R75","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bone.2004.03.008","article-title":"Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta.","volume":"35","author":"Munns","year":"2004","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041114145940800_R76","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMp038103","article-title":"Do bisphosphonates make children\u2019s bones better or brittle?","volume":"349","author":"Marini","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114145940800_R77","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1997.12.10.1700","article-title":"Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis.","volume":"12","author":"Khan","year":"1997","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R78","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMc062792","article-title":"Prolonged bisphosphonate release after treatment in children.","volume":"356","author":"Papapoulos","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114145940800_R79","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/(SICI)1096-9926(199908)60:2<68::AID-TERA10>3.0.CO;2-H","article-title":"Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats.","volume":"60","author":"Patlas","year":"1999","journal-title":"Teratology"},{"key":"key\n\t\t\t\t2019041114145940800_R80","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1359\/JBMR.040711","article-title":"Maternal and fetal outcome after long-term pamidronate treatment before conception: a report of two cases.","volume":"19","author":"Munns","year":"2004","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R81","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ygyno.2004.06.037","article-title":"Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer.","volume":"95","author":"Andreadis","year":"2004","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t2019041114145940800_R82","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJMoa023110","article-title":"Bisphosphonate-induced osteopetrosis.","volume":"349","author":"Whyte","year":"2003","journal-title":"N Eng J Med"},{"key":"key\n\t\t\t\t2019041114145940800_R83","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1359\/JBMR.040814","article-title":"Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate.","volume":"19","author":"Munns","year":"2004","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R84","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/01.bpo.0000152940.10487.c9","article-title":"Bone healing in children with osteogenesis imperfecta treated with bisphosphonates.","volume":"25","author":"Pizones","year":"2005","journal-title":"J Pediatr Orthop"},{"key":"key\n\t\t\t\t2019041114145940800_R85","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.bone.2005.02.016","article-title":"Quantification of metaphyseal modeling in children treated with bisphosphonates.","volume":"36","author":"Ward","year":"2005","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041114145940800_R86","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/j.amjmed.2005.12.020","article-title":"Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?","volume":"119","author":"Bonnick","year":"2006","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041114145940800_R87","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.bone.2008.01.021","article-title":"Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy.","volume":"42","author":"Reginster","year":"2008","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041114145940800_R88","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bone.2007.06.010","article-title":"Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?","volume":"41","author":"Seeman","year":"2007","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041114145940800_R89","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1359\/jbmr.1999.14.10.1664","article-title":"Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development.","volume":"14","author":"Mora","year":"1999","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114145940800_R90","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/jc.2006-1706","article-title":"Sex-and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years.","volume":"92","author":"Rauchenzauner","year":"2007","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/2\/400\/9057704\/jcem0400.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T18:34:07Z","timestamp":1557945247000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/2\/400\/2597898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,1]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2008-1531","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,1]]}}}